275 related articles for article (PubMed ID: 25873863)
1. Defective microglial development in the hippocampus of Cx3cr1 deficient mice.
Pagani F; Paolicelli RC; Murana E; Cortese B; Di Angelantonio S; Zurolo E; Guiducci E; Ferreira TA; Garofalo S; Catalano M; D'Alessandro G; Porzia A; Peruzzi G; Mainiero F; Limatola C; Gross CT; Ragozzino D
Front Cell Neurosci; 2015; 9():111. PubMed ID: 25873863
[TBL] [Abstract][Full Text] [Related]
2. The Role of the Microglial Cx3cr1 Pathway in the Postnatal Maturation of Retinal Photoreceptors.
Jobling AI; Waugh M; Vessey KA; Phipps JA; Trogrlic L; Greferath U; Mills SA; Tan ZL; Ward MM; Fletcher EL
J Neurosci; 2018 May; 38(20):4708-4723. PubMed ID: 29669747
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-induced maternal immune activation modulates microglial CX3CR1 protein expression and morphological phenotype in the hippocampus and dentate gyrus, resulting in cognitive inflexibility during late adolescence.
Fernández de Cossío L; Lacabanne C; Bordeleau M; Castino G; Kyriakakis P; Tremblay MÈ
Brain Behav Immun; 2021 Oct; 97():440-454. PubMed ID: 34343619
[TBL] [Abstract][Full Text] [Related]
4. Role of fractalkine-CX3CR1 pathway in seizure-induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain.
Ali I; Chugh D; Ekdahl CT
Neurobiol Dis; 2015 Feb; 74():194-203. PubMed ID: 25461978
[TBL] [Abstract][Full Text] [Related]
5. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
6. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.
Zhuang ZY; Kawasaki Y; Tan PH; Wen YR; Huang J; Ji RR
Brain Behav Immun; 2007 Jul; 21(5):642-51. PubMed ID: 17174525
[TBL] [Abstract][Full Text] [Related]
7. Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.
Cardona SM; Mendiola AS; Yang YC; Adkins SL; Torres V; Cardona AE
ASN Neuro; 2015; 7(5):. PubMed ID: 26514658
[TBL] [Abstract][Full Text] [Related]
8. Role of CX3CR1 Signaling on the Maturation of GABAergic Transmission and Neuronal Network Activity in the Neonate Hippocampus.
Bertot C; Groc L; Avignone E
Neuroscience; 2019 May; 406():186-201. PubMed ID: 30872165
[TBL] [Abstract][Full Text] [Related]
9. The hippocampal transcriptomic signature of stress resilience in mice with microglial fractalkine receptor (CX3CR1) deficiency.
Rimmerman N; Schottlender N; Reshef R; Dan-Goor N; Yirmiya R
Brain Behav Immun; 2017 Mar; 61():184-196. PubMed ID: 27890560
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury.
Febinger HY; Thomasy HE; Pavlova MN; Ringgold KM; Barf PR; George AM; Grillo JN; Bachstetter AD; Garcia JA; Cardona AE; Opp MR; Gemma C
J Neuroinflammation; 2015 Sep; 12():154. PubMed ID: 26329692
[TBL] [Abstract][Full Text] [Related]
11. The microglial fractalkine receptor is not required for activity-dependent plasticity in the mouse visual system.
Lowery RL; Tremblay ME; Hopkins BE; Majewska AK
Glia; 2017 Nov; 65(11):1744-1761. PubMed ID: 28836393
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex.
Hoshiko M; Arnoux I; Avignone E; Yamamoto N; Audinat E
J Neurosci; 2012 Oct; 32(43):15106-11. PubMed ID: 23100431
[TBL] [Abstract][Full Text] [Related]
13. Impaired brain fractalkine-CX3CR1 signaling is implicated in cognitive dysfunction in diet-induced obese mice.
Kawamura N; Katsuura G; Yamada-Goto N; Novianti E; Inui A; Asakawa A
BMJ Open Diabetes Res Care; 2021 Feb; 9(1):. PubMed ID: 33568358
[TBL] [Abstract][Full Text] [Related]
14. Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1
Cardona SM; Kim SV; Church KA; Torres VO; Cleary IA; Mendiola AS; Saville SP; Watowich SS; Parker-Thornburg J; Soto-Ospina A; Araque P; Ransohoff RM; Cardona AE
Front Cell Neurosci; 2018; 12():365. PubMed ID: 30386211
[TBL] [Abstract][Full Text] [Related]
15. Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice.
Striebel JF; Race B; Carroll JA; Phillips K; Chesebro B
J Gen Virol; 2016 Jun; 97(6):1481-1487. PubMed ID: 26935332
[TBL] [Abstract][Full Text] [Related]
16. Microglia shape presynaptic properties at developing glutamatergic synapses.
Basilico B; Pagani F; Grimaldi A; Cortese B; Di Angelantonio S; Weinhard L; Gross C; Limatola C; Maggi L; Ragozzino D
Glia; 2019 Jan; 67(1):53-67. PubMed ID: 30417584
[TBL] [Abstract][Full Text] [Related]
17. Reduced brain fractalkine-CX3CR1 signaling is involved in the impaired cognition of streptozotocin-treated mice.
Kawamura N; Katsuura G; Yamada-Goto N; Novianti E; Inui A; Asakawa A
IBRO Rep; 2020 Dec; 9():233-240. PubMed ID: 32995659
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine Signaling and Microglia Functions in the Developing Brain.
Arnoux I; Audinat E
Neural Plast; 2015; 2015():689404. PubMed ID: 26347402
[TBL] [Abstract][Full Text] [Related]
19. Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress.
Milior G; Lecours C; Samson L; Bisht K; Poggini S; Pagani F; Deflorio C; Lauro C; Alboni S; Limatola C; Branchi I; Tremblay ME; Maggi L
Brain Behav Immun; 2016 Jul; 55():114-125. PubMed ID: 26231972
[TBL] [Abstract][Full Text] [Related]
20. Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
Reshef R; Kreisel T; Beroukhim Kay D; Yirmiya R
Brain Behav Immun; 2014 Oct; 41():239-50. PubMed ID: 24933434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
